- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07237360
Impact of Prevention of Safe Sleeping and Unexpected Infant Death (MinUTE)
Impact in Pediatric Emergency Departments of a Systematic Individualized Interview Conducted by an Advanced Practice Nurse, on the Prevention of Safe Sleeping and Unexpected Infant Death, in a Population of Infants From 0 to 6 Months
The sudden unexpected infant death (SUID) is defined as "the sudden death of a child aged from 1 month to 1 year who had been healthy until then, whereas nothing in his known history or in the history of events could have allowed him to predict". In France, the French High Autority of Health (Haute Autorité de Santé (HAS)) has set the upper age limit at 2 years.
According to french statistics, between 250 and 350 babies die each year of unexpected infant death. It is the leading cause of infant mortality in developed countries, with all the devastating psychological, social and legal consequences for families. The national prevention campaigns for the "back to sleep" SUID carried out in the 1990s allowed a 75% decrease in the number of SUID. Yet, still at the moment, around 150 deaths could be avoided each year in France by respecting strict dorsal sleeping recommendations and a safe environment.
According to the SUID register of Nantes (France) of April 2024, 75% of deaths occur before the child's six months. The risk factors are mainly prematurity, exposure to tobacco (during and after pregnancy), and a sleeping mode not recommended by HAS. Indeed, on the day of death, 20% of babies were lying on their stomach or side, 30% shared their bed and 59% were lying in bedding at risk of containment or obstruction of the upper airway.
According to the database of National Association of Infant Death Unexpected Reference Centers since 2022, there has been a resurgence in the number of these deaths. This proves the urgency of prevention on this public health issue.
In parallel, we do not know why the number of SUID is not decreasing in correlation with the decrease in the birth rate in France. Moreover, it would be interesting to know the reasons why parents do not follow the recommendations of the HAS for their baby to sleep safely.
Thus, I wish to evaluate the impact of systematic prevention by the Advanced Practice Nurse with the parents of infants aged 0 to 6 months presenting to the Pediatric Emergency and know their barriers/levers to change.
My research question is therefore titled:
Why and how many infants under 6 months sleep in insecurity compared to lying babies according to the international recommendations ?
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Gaëlle SORIN
- Phone Number: +33241354427
- Email: gaelle.sorin@chu-angers.fr
Study Contact Backup
- Name: Elise HOUSSIN
- Email: DRCI-Promotion-Interne@chu-angers.fr
Study Locations
-
-
-
Angers, France, 49933
- Chu Angers
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- All parents consulting the Pediatric Emergency Department of University Hospital of Angers for their baby aged 0 to 6 months
Exclusion Criteria:
- Any other person consulting for a baby aged 0 to 6 months who is not the parent of the baby: a grandparent, an uncle, an aunt, a childminder, the nursery manager, a friend of the parents, etc.
- Parent refusing the use of their data
- Parent and/or child under legal protection
- Parent who does not understand French
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Emergencies babies
|
Smoking habits, socio-professional category
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Increase in the number of babies lying well on their backs after the guided interview VS the number of babies lying well on their backs before the guided interview
Time Frame: During the interview of the family, about 1 hour
|
During the interview of the family, about 1 hour
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 49RC25_0113
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prevention & Control
-
Vanderbilt UniversityNational Institute of Mental Health (NIMH)RecruitingPrevention | ControlUnited States
-
Gunilla FahlstromÖrebro County Council; Örebro University, SwedenCompleted
-
Beijing Friendship HospitalRecruitingColorectal Cancer Control and PreventionChina
-
University Rovira i VirgiliCompletedHealthy People Programs | Prevention and ControlSpain
-
University of North Carolina, Chapel HillMedtronic - MITGCompletedPrevention & Control | Sterilization, Tubal | Salpingectomy | OvaryUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH); University of MinnesotaRecruitingSmoking Prevention and ControlUnited States
-
University of South CarolinaActive, not recruitingTaekwondo-based Fall Prevention Exercise Condition | Fall Prevention Education Control ConditionUnited States
-
University of BarcelonaCompleted
-
Erasmus Medical CenterAmbu A/S; Maag Lever Darm StichtingCompletedEsophagogastroduodenoscopy | Gastroscopy | Equipment Design | Equipment Contamination / Prevention & Control | Cross Infection / Prevention & Control | Disposable Equipment | Infection Control / MethodsNorway, Netherlands
-
Gulf Medical UniversityAlva's College of PhysiotherapyCompletedAthletic Injuries/Prevention and ControlUnited Arab Emirates
Clinical Trials on Sleeping mode
-
University of BradfordCompleted
-
Centre Hospitalier Régional d'OrléansWithdrawnRetinal Vein Occlusion | Obstructive Sleep ApneaFrance
-
Nathalie CharpakHospital Universitario San Ignacio; Pontificia Universidad JaverianaCompletedPhototherapy | Jaundice, NeonatalColombia
-
Radboud University Medical CenterLeiden University Medical Center; Michael J. Fox Foundation for Parkinson's...Active, not recruitingParkinson Disease | ParkinsonismNetherlands
-
Masonic Cancer Center, University of MinnesotaWithdrawnMucopolysaccharidosis Type IH | Mucopolysaccharidosis Type IH (MPS IH, Hurler Syndrome) | MPS IH, Hurler Syndrome
-
M.D. Anderson Cancer CenterAmerican Cancer Society, Inc.WithdrawnGastrointestinal Cancer | GI CancersUnited States
-
University of PortsmouthUniversity College, London; University of Cambridge; Portsmouth Hospitals NHS... and other collaboratorsCompleted
-
Children's Hospital of PhiladelphiaMinnesota HealthSolutionsCompletedDistracted DrivingUnited States
-
Université de MontréalCompletedSleep Apnea, ObstructiveCanada